海南海藥(000566.SZ):子公司收到藥品GMP檢查結果通知書
格隆匯10月22日丨海南海藥(000566.SZ)公佈,公司控股子公司海口市制藥廠有限公司(“海口市制藥廠”)於近日收到海南省藥品監督管理局核准簽發的《藥品GMP符合性檢查結果通知書》(編號:瓊藥監藥產F2021019)。
海南省藥品監督管理局依據《藥品生產質量管理規範(2010年修訂)》的要求進行檢查,經綜合評定認為:海口市制藥廠位於海南省海口市秀英區南海大道192號的片劑、硬膠囊劑(DK車間,多功能口服生產線)生產範圍符合藥品生產質量管理規範要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.